Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases.
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia.
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc., together with its subsidiaries, operates as a clinical-stage biopharmaceutical company.